Ganzhou Mingzhen Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Ganzhou Mingzhen Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include THEMOXIA. The owner is based in Ganzhou, Jiangxi.

206-3, 2F, Moon Bay Innovation and

Ganzhou, Jiangxi 342600 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

THEMOXIA
THEMOXIA
Registered 2023

Trademark Classifications

Ganzhou Mingzhen Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Ganzhou Mingzhen Biotechnology Co., Ltd. have?

Ganzhou Mingzhen Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Ganzhou Mingzhen Biotechnology Co., Ltd. file in?

Ganzhou Mingzhen Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Ganzhou Mingzhen Biotechnology Co., Ltd.'s most well-known trademarks?

Ganzhou Mingzhen Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as THEMOXIA. These are among 1 currently registered trademark in the portfolio.

What is Ganzhou Mingzhen Biotechnology Co., Ltd.'s trademark registration success rate?

Ganzhou Mingzhen Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.